Sanara Medtech Inc
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness w… Read more
Sanara Medtech Inc (SMTI) - Total Liabilities
Latest total liabilities as of September 2025: $64.95 Million USD
Based on the latest financial reports, Sanara Medtech Inc (SMTI) has total liabilities worth $64.95 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sanara Medtech Inc - Total Liabilities Trend (1999–2024)
This chart illustrates how Sanara Medtech Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sanara Medtech Inc Competitors by Total Liabilities
The table below lists competitors of Sanara Medtech Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Atinum Investment Co. Ltd
KQ:021080
|
Korea | ₩16.58 Billion |
|
Century Enka Limited
NSE:CENTENKA
|
India | ₹3.13 Billion |
|
Carlo Gavazzi Holding AG
SW:GAV
|
Switzerland | CHF39.69 Million |
|
SaltX Technology Holding AB
ST:SALT-B
|
Sweden | Skr35.73 Million |
|
Cupid Limited
NSE:CUPID
|
India | ₹610.07 Million |
|
Escort Teknoloji Yatirim AS
IS:ESCOM
|
Turkey | TL67.47 Million |
|
GnBS Engineering Co. Ltd.
KQ:382800
|
Korea | ₩22.65 Billion |
|
Havanna Holding SA
BA:HAVA
|
Argentina | AR$76.84 Billion |
Liability Composition Analysis (1999–2024)
This chart breaks down Sanara Medtech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 10.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.91 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sanara Medtech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sanara Medtech Inc (1999–2024)
The table below shows the annual total liabilities of Sanara Medtech Inc from 1999 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $49.18 Million | +67.95% |
| 2023-12-31 | $29.28 Million | +51.61% |
| 2022-12-31 | $19.32 Million | +209.32% |
| 2021-12-31 | $6.24 Million | +56.66% |
| 2020-12-31 | $3.99 Million | -15.64% |
| 2019-12-31 | $4.72 Million | +144.81% |
| 2018-12-31 | $1.93 Million | -8.76% |
| 2017-12-31 | $2.12 Million | -18.46% |
| 2016-12-31 | $2.59 Million | -2.58% |
| 2015-12-31 | $2.66 Million | +14.60% |
| 2014-12-31 | $2.32 Million | -32.56% |
| 2013-12-31 | $3.45 Million | -33.73% |
| 2012-12-31 | $5.20 Million | -32.41% |
| 2011-12-31 | $7.69 Million | +96.51% |
| 2010-12-31 | $3.91 Million | +59.28% |
| 2009-12-31 | $2.46 Million | +419.61% |
| 2008-12-31 | $472.97K | -78.69% |
| 2007-12-31 | $2.22 Million | +25.59% |
| 2006-12-31 | $1.77 Million | +95.22% |
| 2005-12-31 | $905.27K | +458.02% |
| 2004-12-31 | $162.23K | -95.44% |
| 2001-12-31 | $3.56 Million | +41.53% |
| 2000-12-31 | $2.52 Million | +37.64% |
| 1999-12-31 | $1.83 Million | -- |